Zoom's share price drops 17 per cent
Zoom's share price dropped as much as 17 per cent today following news that a COVID vaccine has proved effective in trials. Preliminary analysis shows that a vaccine developed by US firm Pfizer ...
To continue reading this article...
Join CRN
- Enjoy full access to channelweb.co.uk - the UK’s top news source for the IT channel
- Gain the latest insights through market analysis and interviews with channel leaders
- Stay on top of key trends with the Insider weekly newsletter curated by CRN’s editor
- Be the first to hear about our industry leading events and awards programmes
Already a CRN member?
